Nephrology Doctors in Albany, GA Accepting Medicare

6 Nephrology doctors found. Showing 1 - 6

Jeffrey L Bell, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Jefferson St, Albany, GA 31701 Phone: 229-888-3970    Fax: 229-889-9386

Dr. Mufaddal F Kheda, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1200 N Jefferson St, Albany, GA 31701 Phone: 229-888-3970    Fax: 229-888-7771

Michael L Sobel, DO Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-1000

Dr. Salim Bou Slaiman, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Jefferson St, Albany, GA 31701 Phone: 718-226-9000

John Joseph Schilling, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Jefferson St, Albany, GA 31701 Phone: 229-888-3970    Fax: 229-889-9386

Annie Mae Walker, NP Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Jefferson St, Albany, GA 31701 Phone: 229-888-3970

News Archive

State highlights: Battle over Brooklyn hospital's fate widens in court

Justice Johnny L. Baynes in Brooklyn, who has issued three temporary restraining orders in the case since March, all forbidding SUNY to take steps to close [Long Island College Hospital], asked a lawyer representing Bill de Blasio, the public advocate and a Democratic candidate for mayor, whether he had reported allegations of criminal interference with emergency room services to the Brooklyn district attorney. Murmurs of approval rose from the room, packed with longtime patients, doctors, nurses and residents of northern Brooklyn where the fate of the 150-year-old hospital has become a rallying cry (Bernstein, 8/7).

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.

Adding therapy helps adolescents with depression not responding to SSRIs

For adolescents with depression not responding to an initial treatment with a selective serotonin reuptake inhibitor (SSRI; a class of antidepressant drugs), switching medications and adding cognitive behavioral therapy resulted in an improvement in symptoms, compared to just changing medications, according to a study in the February 27 issue of JAMA: The Journal of the American Medical Association.

Dozens of U.S. hospitals poised to defy FDA's directive on COVID plasma

Dozens of major hospitals across the U.S. are grappling with whether to ignore a federal decision allowing broader emergency use of blood plasma from recovered COVID patients to treat the disease in favor of dedicating their resources to a gold-standard clinical trial that could help settle the science for good.

Menopausal hormone therapy may protect women from stress' negative effects on memory

Menopausal hormone therapy may shield women from stress' negative effects on some types of memory, according to a small-scale study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Read more Medical News

› Verified 4 days ago